|
|
|
|
|
|
|
| publications | ||||||
| 1. ������� Funakoshi H., Fris�n J., Barbany G., Timmusk T., Zachrisson O., Verge V.M.K. and Persson H. Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J. Cell Biol.123, (1993) 455-465. | ||||||
| 2. ������� Zachrisson O., Math� A.A., Stenfors C. and Lindefors N. Limbic effects of repeated electroconvulsive stimulation on neuropeptide Y and somatostatin mRNA expression in the rat brain. Mol. Brain Res. 31, (1995) 71-85. | ||||||
| 3. ������� Zachrisson O., Math� A.A., Stenfors C. and Lindefors N. Region-specific effects of chronic lithium administration on neuropeptide Y and somatostatin messenger RNA expression in the rat brain. Neurosci. Lett.194, (1995) 89-92. | ||||||
| 4. ������� Zachrisson O., Falkenberg T. and Lindefors N. Neuronal coexistence of trkB and glutamic acid decarboxylase67 mRNAs in rat hippocampus. Mol. Brain Res. 36, (1996) 169-173. | ||||||
| 5. ������� Zachrisson O., Math� A. A. and Lindefors N. Effects of chronic lithium and repeated electroconvulsive shock administration on cholecystokinin mRNA expression in the rat brain. Mol. Brain Res.43, (1996) 347-350 | ||||||
| 6. ������� Zachrisson O. and Lindefors N. Kolecystokinin-receptors in the brain ?Target for tomorrow?s psychoactive drugs? L�kartidningen 93, (1996) 1225-1227. | ||||||
| 7.������� Zachrisson O., Math� A. A. and Lindefors N. Decreased levels of preprotachykinin-A and tachykinin NK1 receptor mRNA in specific regions of the rat striatum after electroconvulsive stimuli. Eur. J. Pharmacol.391, (1997) 191-195 | ||||||
| 8. ������� Marcus M.M., Nomikos G.G. , Malmerfelt A., Zachrisson O., Lindefors N. and Svensson T.H.Effect of chronic antipsychotic treatment on preprosomatostatin and preprotachykinin A mRNA levels in the medial prefrontal cortex, the nucleus accumbens and the caudate putamen of the rat. Mol. Brain Res.45, (1997) 275-282 | ||||||
| 9. ������� Falkenberg T., Lindefors N., O'Connor W.T., Zachrisson O., Camilli F. and Ungerstedt U. Differential and dose-dependent effects on GABA release and GAD67 mRNA expression in rat hippocampus following entorhinal cortex activation. Mol. Brain Res.48, (1997) 275-282 | ||||||
| 10. ����� Zachrisson O., Marcus M.M., Nomikos G.G., Math� A.A., Svensson T.H., and Lindefors N. Effects of antipsychotic treatments on neuropeptide mRNA expression in the hippocampal formation of the rat. Soc. Neurosci. Abstr. (1997) 384.16 | ||||||
| 11. ����� Zachrisson O., Lindefors N. and Bren� S. A tachykinin NK1 receptor antagonist, CP-122,721-1, attenuates kainic acid-induced seizure activity. Mol. Brain Res.60, (1998) 291-295 | ||||||
| 12.����� Zachrisson O., deBelleroche J., Hirsch S., Wendt K., and Lindefors N. Expression of two isoforms of cholecystokinin CCKB receptor mRNA in human post-mortem brains from schizophrenic patients. NeuroReport 10, (1999) 3265-3268 | ||||||
| 13. Lee Y.-J., Zachrisson O., Tonge D.A. and McNaughton P.A. Upregulation of bradykinin B2 receptor gene expression in mouse sensory neurones by NGF and nerve injury, J. Physiol.518, (1999)153 | ||||||
| 14. Zachrisson O., Marcus M.M., Nomikos G.G, Svensson T.H. and Lindefors N. Effects of antipsychotic drugs on cholecystokinin and preprotachykinin (substance P) mRNA expression in the rat hippocampal formation. Eur. Neuropsychopharmacol. 10, (2000) 355-363 | ||||||
| 15.������ Lee,Y.-J., Zachrisson, O., Tonge, D.A. & McNaughton, P.A. (2001) Effects of media conditioned by lesioned tissues on bradykinin B2 receptor expression in adult mouse sensory neurones. J.Physiol. (in press). | ||||||
| ����������� | ||||||